Analysis published 06 Apr 2026

AI-generated · cited to primary sources · not investment advice

Aarti Industries (524208) May 2025 Filing Analysis

01 · Management Credibility

Does management do what it says?

In progressBackward Integration into Key Building Blocks
60/100

The project (Zone 4) is progressing as per plan with chemical charging started for specific blocks. (1 in progress across 1 tracked commitment)

hopefully and potentially the chlorotoluene which is likely to also come in the second half of FY 26

Aarti Industries · Concall Transcript · May 2025 · p.13
Pharma Intermediate Demand Growth

Management expects positive developments in the domestic market share of PNCB in the PAP/downstream market starting from H1-FY26. — target: Positive developments in market share

Domestic market share of PNCB in PAP/ downstream market expected to have positive developments from H1-FY26

Aarti Industries · Investor PPT · May 2025 · p.14

See the full cited Management analysis of Aarti Industries

Create free account →
02 · Business Model

How durable is the business?

Green Chemistry and Sustainable Processes
80/100

The company is aggressively expanding its cost moat through a dedicated 'Cost Optimisation' program targeting Rs 150-200 Cr in EBITDA impact. (5 expanding)

Cost Optimisation ₹ 150-200 Cr: Switching to BPT to improve Cogen, Renewable Power phase 2, Yield improvement

Aarti Industries · Investor PPT · May 2025 · p.17
EBITDA Margin
47/100

The Energy segment remains the largest revenue contributor but is experiencing margin compression due to pricing pressures, despite volume growth. (2 contracting, 1 expanding)

Energy end application getting stabilized driven by higher volumes but lower margins due to pricing pressure... FY25 Revenue Share 36%

Aarti Industries · Investor PPT · May 2025 · p.11

See the full cited Business Model analysis of Aarti Industries

Create free account →
03 · Future Growth

Where does growth come from?

China-Plus-One Structural Beneficiary

The US tariff actions against China are creating an immediate positive tailwind for specific chains like PDA (MPD), leading to higher anticipated utilization. (3 new trend across 3 signals)

MPD is one of the product in PDA chain where in the near term we are seeing positive demand traction because it's not part of exemption and the competition was from China, so there is a clear-cut advantage.

Aarti Industries · Concall Transcript · May 2025 · p.8

See the full cited Future Growth analysis of Aarti Industries

Create free account →
04 · Risk

What could break the thesis?

China-Plus-One Structural Beneficiary

The risk is transitioning into a potential opportunity. Management notes that the US tariff situation on China may create new market opportunities for Indian exports due to tariff differentials. (1 easing)

US Tariff situation may create new market opportunities... Potential opportunities for Indian exports to the US due to tariff differential with China

Aarti Industries · Investor PPT · May 2025 · p.13
Multi-Chemistry Platform Value (PRINCIPLE)

The risk is stable but remains a focus. MMA volumes grew 38% over two years, but pricing is volatile and linked to gasoline/naphtha spreads which are difficult to forecast. New Chinese competition (4 lakh ton capacity) is also emerging. (1 stable)

Frankly, I would be totally honest, it is very difficult for us to forecast gasoline-naphtha spreads... what we remain focused on is to ensure that... the product is available to more and more customers in the global market.

Aarti Industries · Concall Transcript · May 2025 · p.8
Green Chemistry and Sustainable Processes

The risk is stable as pricing pressures persist, but management is aggressively pursuing cost-efficiency projects. EBITDA for FY25 (₹ 1016 Cr) was at the lower end of the projected range, confirming the squeeze. (1 stable, 1 easing)

Several planned Variable and Fixed cost optimization initiatives were completed in FY25... Process optimisation driving cost savings

Aarti Industries · Investor PPT · May 2025 · p.10

See the full cited Risk analysis of Aarti Industries

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.